PEDIATRICS Vol. 98 No. 2 August 1996, pp. 315
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doctor, A.
Right arrow Articles by Fleisher, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doctor, A.
Right arrow Articles by Fleisher, G. R.

Letter To The Editor

Allan Doctor MD1, Marvin B. Harper MD2, and Gary R. Fleisher MD3

1 Division of Critical Care, Children's Hospital, Boston, MA 02115
2 Division of Emergency Medicine, Division of Infectious Diseases, Children's Hospital, Boston, MA 02115
3 Division of Emergency Medicine, Children's Hospital, Boston, MA 02115

We agree with Dr Goldsmith's caution in projecting trends from any case series. We would also like to take this opportunity to present the incidence of group A beta-hemolytic streptococcus (GABHS) complications in children with varicella-zoster virus (VZV) at our institution since the data collection period of our prior study.1 In 1994, there were four children with GABHS bacteremia, none with VZV; in addition, four children were hospitalized with GABHS complications (cultures of sterile sites other than blood) during VZV infection (two with osteomyelitis, two with deep abscesses).